Author:
Kendrick Jennifer,Warkentin Dawn,Ensom Mary H. H.
Reference68 articles.
1. Hunter RJ, Navo MA, Thaker PH, Bodurka DC, Wolf JK, Smith JA (2009) Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA). Cancer Treat Rev 35:69–78
2. Rogers PC, Meacham LR, Oeffinger KC, Henry DW, Lange BJ (2005) Obesity in pediatric oncology. Pediatr Blood Cancer 45:881–891
3. Navarro WH (2003) Impact of obesity in the setting of high-dose chemotherapy. Bone Marrow Transplant 31:961–966
4. Blouin RA, Ensom MHH (2006) Special pharmacokinetic considerations in the obese. In: Burton ME, Shaw LM, Schentag JJ, Evans WW (eds) Pharmacokinetics and pharmacodynamics: principles of therapeutic drug monitoring, 4th edn. Lippincott Williams & Wilkins, Baltimore, MD, p 231
5. Kendrick JG, Carr RR, Ensom MHH (2010) Pharmacokinetics and drug dosing in obese children. J Pediatr Pharmacol Ther 15:94–109
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献